openPR Logo
Press release

Rheumatology Therapeutics Market Estimated to Flourish by 2025

11-14-2017 07:37 AM CET | Health & Medicine

Press release from: Transparency Market Research

Rheumatology Therapeutics Market Estimated to Flourish by 2025

Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. Some other key players in the market are Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical.

A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025 to become worth US$ 52.96 bn by 2025 from US$41.88 bn in 2016.

The various drug classes in the global rheumatology therapeutics market are disease modifying anti-rheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAID’s), corticosteroids, uric acid drugs, etc. The DMARDs, which is a group of medicines or combination of medicines used to treat rheumatic diseases by blocking the inflammation, accounts for maximum share in the market at present. They are categorized into two major types - biologic DMARDs and synthetic DMARDs. By rising at a 2.6% CAGR from 2017 to 2025 the segment is expected to retain its dominant share in the upcoming years.

Geographically, the key segments of the global rheumatology therapeutics market are North America, South America, Europe, Asia Pacific, and the Middle East and Africa. Of them, North America leads the market with dominant share on account of a burgeoning geriatric population highly susceptible to various kinds of rheumatology disorders. Further, uptake of biologics and biosimilar products for treating moderate to severe rheumatoid arthritis and superior healthcare facilities has also proved beneficial to the market in the region.

Read Report Overview @ https://www.transparencymarketresearch.com/rheumatology-therapeutics-market.html

Rheumatology is the multidisciplinary approach towards the diagnosis and treatment of the various rheumatic disease which includes clinical problems in joints, soft tissues, heritable connective tissue disorders, vasculitis, and autoimmune diseases. Rheumatic disease is associated with inflammation that affects the bones, tendons, ligaments, and sometimes organs.

At the forefront of driving growth in the global rheumatology therapeutics market is the ever-increasing elderly population worldwide and swift approval of new drugs for treating various rheumatic diseases. In August 2017, for example, the FDA approved DUZALLO drug by Ironwood Pharmaceuticals, Inc. and AstraZeneca. It is the first and only therapy that leverages two types of mechanisms in gout with only one pill. Again, in 2017, Kevzara (Sanofi and Regeneron Pharmaceuticals, Inc.) got the FDA approval to treat adult patients with moderately to severely active rheumatoid arthritis (RA). In 2017, AbbVie Inc., a global leader in anti-rheumatic drugs, announced its four potential candidates, which are Upadacitinib, Risankizumab, ABBV-599, and ABT-981, that are in different phases of clinical trials to treat conditions such as rheumatoid arthritis, psoriatic arthritis, and osteoarthritis (OA).

Request Sample Report @https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1494

Investment into Research and Development Benefits Market

Other factors positively influencing the market are rising knowledge among people about rheumatic diseases and emergence of cost-effective rheumatology therapeutics. Further, increasing investment in research and development is likely to bolster the growth of global rheumatology therapeutics market during the forecast period.

Request Rheumatology Therapeutics Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1494

This review is based on the findings of a TMR report, titled, “Rheumatology Therapeutics Market (Drug Class – Disease Modifying Anti-rheumatic Drugs (DMARD’s), Nonsteroidal Anti-inflammatory Drugs (NSAID’s), Corticosteroids, and Uric Acid Drugs; Disease Indication – Rheumatoid Arthritis, Osteoarthritis, Gout, Psoriatic Arthritis, and Ankylosing Spondylitis; Distribution Channel – Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025.”

Buy Full Rheumatology Therapeutics Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=1494<ype=S

About TMR

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact

Transparency Market Research
State Tower
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
TMR Blog: http://www.theglobalhealthnews.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rheumatology Therapeutics Market Estimated to Flourish by 2025 here

News-ID: 814759 • Views: 137

More Releases from Transparency Market Research

Zinc–Bromine Batteries Market – Precise Analysis on Business Overview, Produ …
Zinc–bromine battery is a redox flow battery. A redox flow battery is the one in which most of the energy is stored by plating zinc as a solid on the anode during charging. In a cell of the zinc–bromine battery, there are two compartments filled with two different electrolytes. The two compartments are separated by a microporous polyolefin membrane. One electrolyte comes into action when a positive electrode reaction takes
Wastewater Treatment Diffuser Market: Rising Adoption from Small and Medium-size …
Wastewater Treatment Diffuser Market – Overview Wastewater treatment diffuser is the primary equipment used to introduce air into liquid and provides an environment for microbial degradation of matter. Clean water is needed both for domestic and industrial purpose. There are two uses of aeration: to bring microorganisms into close contact with the suspended and dissolved organic matter and to supply the required oxygen (oxidation process) to the metabolizing microorganisms. Major applications
Emollient Esters Market – Global Segments, Top Key Players, Size and Recent Tr …
Emollient is a common ingredient used in personal care formulations. Emollients are elements that impart a soft or smooth effect to the skin. Emollients are multifunctional ingredients that offer numerous benefits to the users, such as moisturizing and enhancing the texture of hair and skin, reducing skin blemishes and wrinkles, supplementing cell count, thickening anhydrous water in oil and oil in water formulations, while acting as an active solvent at
High Performance Liquid Chromatography (HPLC) Packing Materials Market Competiti …
High-performance liquid chromatography (HPLC), formerly referred to as high-pressure liquid chromatography), is a technique in analytical chemistry used to separate, identify, and quantify each component in a mixture. It relies on pumps to pass a pressurized liquid solvent containing the sample mixture through a column filled with a solid adsorbent material. Each component in the sample interacts slightly differently with the adsorbent material, causing different flow rates for the different

All 5 Releases


More Releases for Rheumatology

Rheumatology Therapeutics Market
Global Rheumatology Therapeutics Market: Snapshot A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global rheumatology therapeutics market. This has led to the emergence of many new drugs. Their swift approvals by the appropriate authorities has also led to the growth in the market. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology
Increasing burden of rheumatology diseases globally is propelling the growth of …
Rheumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to
Rheumatology Therapeutics Market-Technological Breakthroughs by 2025
heumatology diseases affects the supporting or connecting structures of the body mostly joints, ligaments, muscles, tendons, and rarely some organs of the body. This disease is characterized by inflammation of joints and it affects spine in some types of rheumatology disease. There are more than 100 types of rheumatic disease. It is caused by various genetic and environmental factors, such as unhealthy diet and changing lifestyle, which can lead to
Rheumatology Therapeutics Market: Raft Approvals for New Drugs Boosts Growth
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. Some other key players in the market are Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical. Request for Sample Copy of Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1494 A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster
Rheumatology Therapeutics Market: Burgeoning Elderly Population Drives Growth
Prominent companies operating in the global rheumatology therapeutics market are AbbVie, Inc., Pfizer, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc. etc. Some other key players in the market are Amgen, Inc., Janssen Biotech, Inc., Novartis AG, Genentech, Inc., Sanofi, and Takeda Pharmaceutical. A report by Transparency Market Research uncovers after in-depth study that the global rheumatology therapeutics market will rise at a lackluster CAGR of 2.7% from 2017 to 2025
Global Rheumatology Market to 2024
Global rheumatology market was valued at $31bn in 2015 and is forecast to grow at a modest 4.0% CAGR between 2015 and 2024 to reach 2024 global sales of $46bn. http://optimainsights.org/request-toc/global-rheumatology-market-to-2024 Rheumatology encompasses numerous musculoskeletal and autoimmune diseases that cause systemic manifestations including joint pain, inflammation and destruction. Worldwide, over 470 million people suffer from rheumatologic diseases. Rheumatology represents a significant disease burden with annual costs associated with rheumatologic diseases estimated at